Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Eagle Pharmaceutical (EGRX)

65.02 1.57 (2.47%)

02-22 16:00

Open:

63.89

Pre. Close:

63.45

High:

65.05

Low:

63.2

Volume:

249,779

Market Cap:

970M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

65.11 - 65.361

65.361 - 65.648

Low:

62.522 - 62.789

62.789 - 63.097

Close:

64.513 - 64.951

64.951 - 65.454

Technical analysis  (as of: 2018-02-22 5:00:58 PM)

Overall:

      

Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 77.15     One year: 90.11

Support:

Support1: 58.46    Support2: 53.77

Resistance:

Resistance1: 66.05    Resistance2: 77.15

Pivot:

60.58

Moving Averages:

MA(5): 64.21     MA(20): 60.47

MA(100): 57.28     MA(250): 66.50

MACD:

MACD(12,26): 1.41     Signal(12,26,9): 0.86

%K %D:

%K(14,3): 81.73     %D(3): 83.32

RSI:

RSI(14): 62.61

52-Week:

High: 97.15  Low: 45.05  Change(%): -14.4

Average Vol(K):

3-Month: 22403  10-Days 23279

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
EGRX has closed below upper band by 12.4%. Bollinger Bands are 60.6% wider than normal. The large width of the bands suggest high volatility as compared to EGRX's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

Thu, 15 Feb 2018 21:22:30 GMT
Eagle Pharmaceuticals, Inc. to Discuss Fourth Quarter and Year End 2017 ...

Mon, 12 Feb 2018 21:22:30 GMT
Eagle Pharmaceuticals, Inc. to Present at 2018 RBC Capital Markets Global ...

Thu, 22 Feb 2018 20:37:30 GMT
Eagle Pharmaceuticals Inc (EGRX) Receives $63.67 Consensus Price Target from ...

Wed, 07 Feb 2018 12:22:30 GMT
Eagle Pharmaceuticals (EGRX) Announces Fifth Orange Book Listed Patent for ...

Tue, 20 Feb 2018 17:03:45 GMT
Commit To Buy Eagle Pharmaceuticals At $60, Earn 27.3% Annualized Using Options

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

14.92

Shares Float (M)

13.46

% Held by Insiders

% Held by Institutions

Shares Short (K)

3011

Shares Short Prior Month (K)

3890

Stock Financials

EPS

6.340

EPS Est. Current Year

3.790

EPS Est. Next Year

4.400

EPS Est. Next Quarter

1.050

Forward EPS

4.351

Book Value (p.s.)

5.650

PEG Ratio

0.90

Profit Margin

22.57

Operating Margin

34.86

Return on Assets (ttm)

47.7

Return on Equity (ttm)

71.2

Qtrly Rev. Growth

66.6

Gross Profit (p.s.)

13.991

Sales Per Share

EBITDA (p.s.)

6.390

Qtrly Earnings Growth

29.10

Operating Cash Flow (M)

72.55

Levered Free Cash Flow (M)

41.98

atoplab.com

Valuation

P/E

10.26

P/E Growth Ratio

0.02

P/BV

11.51

P/S

54408208.00

P/CF

13.37

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.